Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule
Year: 2018
Type: conference-abstract
Source: Blood
Institutions: Dana-Farber Cancer Institute, Harvard University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2910619480
